A federal panel of vaccine experts punted the decision to recommend a third COVID-19 shot for immunocompromised people to the Food and Drug Administration after a full day of public debate.
KIDNEY TRANSPLANT RECIPIENTS STILL VULNERABLE TO COVID-19 POST-VACCINATION
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.